Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/15/17 → 11/15/20 |
Funding
- Parexel (Prot #RD.03.SPR.114322 // Prot #RD.03.SPR.114322)
- Galderma Research & Development, SNC (Prot #RD.03.SPR.114322 // Prot #RD.03.SPR.114322)
Prot #RD.03.SPR.114322: A randomized, double-blind, multi-center, parallel-group, placebo-controlled dose-ranging study to assess the efficacy and safety of nemolizumab (CD14152) in moderate-to-severe atopic dermatitis subjects with severe pruritus receiv
- Silverberg, Jonathan I (PD/PI)
Project: Research project